Interferon Alfa Sensitivity in HIV/HCV Coinfected Persons Before and After Antiretroviral Therapy.

Trial Profile

Interferon Alfa Sensitivity in HIV/HCV Coinfected Persons Before and After Antiretroviral Therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Peginterferon alfa-2b (Primary) ; Antiretrovirals; Emtricitabine/tenofovir disoproxil fumarate; Raltegravir
  • Indications Hepatitis C; HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2017 Results assessing intracellular HIV-1 RNA and CD4+ t cell activation (n=19), published in the AIDS
    • 26 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top